发明名称 |
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects |
摘要 |
This disclosure relates to methods administering various compounds in conjunction with dextromethorphan to a human being. Dosage forms, drug delivery systems, and methods related to dextromethorphan or dextrorphan and bupropion, hydroxybupropion, erythrohydroxybupropion, threohydroxybupropion, or a metabolite or prodrug of any of these compounds are also disclosed |
申请公布号 |
US2016375012(A1) |
申请公布日期 |
2016.12.29 |
申请号 |
US201615263138 |
申请日期 |
2016.09.12 |
申请人 |
ANTECIP BIOVENTURES II LLC |
发明人 |
Tabuteau Herriot |
分类号 |
A61K31/485;A61K9/00;A61K31/137 |
主分类号 |
A61K31/485 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of correcting extensive metabolism of the dextromethorphan in a human subject in need thereof, comprising co-administering to the human subject once a day for at least eight consecutive days or twice a day for at least eight consecutive days:
1) a hydroxybupropion, a threohydroxybupropion, a erythrohydroxybupropion or a bupropion; and 2) a dextromethorphan;wherein the daily dose of the dextromethorphan is about 40 mg to about 350 mg, and co-administration of the hydroxybupropion, the threohydroxybupropion, the erythrohydroxybupropion or the bupropion, and the dextromethorphan results in a first AUC0-24 of the dextromethorphan that is at least about 50 ng·hr/mL, and the first AUC0-24 of the dextromethorphan is at least about 20 times a second AUC0-24 of the dextromethorphan that would result from administering the daily dose of the dextromethorphan without the hydroxybupropion, the threohydroxybupropion, the erythrohydroxybupropion or the bupropion to the human subject. |
地址 |
New York NY US |